Latest news

July 18, 2017

“Recognizing Sepsis as a Global Health Priority — A WHO Resolution” in the New England Journal of Medicine

On June 29, 2017, the prestigious New England Journal of Medicine published an article detailing the Global Sepsis Alliance’s (GSA) perspective on the World Health Organization (WHO) resolution on improving the prevention, diagnosis, and management of sepsis. 

July 11, 2017

Focus on sepsis

Shahrzad Kiavash was anesthetized for almost 2 weeks and stayed in the hospital for seven months. Both her lower legs were amputated. Sepsis almost cost her life. Today, Shahrzad Kiavash competes in triathlon – where swimming, cycling and running are all included in the same race. 

June 21, 2017

Lund researchers awarded prestigious Global Sepsis Award

Every year 40 000 Swedes suffer from sepsis, with mortality rates as high as 20 percent. Even though the disease is almost as common as cancer, few Swedes have ever heard of it. 

Latest press releases

August 10, 2017

Interim report for Q2 2017

Bactiguard saves lives by preventing healthcare associated infections. With the development in the second quarter, sales of our own product portfolio have now increased for seven consecutive quarters, based on rolling twelve-month figures. This means that more patients have access to effective and safe infection prevention. The value of delivered products increased by approx. 76 %, due to higher volumes and improved product mix. Higher license revenues contribute considerably to the increase in total revenue compared with previous year. With continued cost control, EBITDA also improved and we reached an EBITDA margin of 11 %. Marketwise, the biggest breakthrough in the quarter was the tender we won in Stockholm. New partnerships were also established for Brazil, Italy and South Africa.

August 07, 2017

Invitation to presentation of Bactiguard's interim report on August 10, 2017

Bactiguard Holding AB (publ) publishes the interim report for the second quarter on Thursday, August 10, 2017 at 8:00 CET.

July 21, 2017

New Team Bactiguard

Good to Great Tennis Academy and Swedish medtech company Bactiguard AB have today announced that they are continuing to strengthen the development of future tennis talent in Sweden by focusing on younger players between 13 to 14 years of age. Together, Good to Great Tennis Academy and Bactiguard have created a new Team Bactiguard consisting of five promising tennis players in Sweden.